Cannara Biotech's total assets for Q4 2025 were C$168.65M, a decrease of -0.85% from the previous quarter. LOVFF total liabilities were C$66.43M for the fiscal quarter, a -7.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.